Skip to main content
ASTH logo

ASTH · Astrana Health, Inc. · Holdings

Track ASTH — free
Market Cap
$1.61B
Shares
55.80M
Volume · Nov 20 441.03K Avg daily vol (3M) 377.55K

Institutional ownership from SEC Form 13F filings. Investment managers with more than $100 million in U.S. equities must disclose their positions every quarter, within 45 days of quarter-end, so the holdings shown can lag the market by up to a quarter.

Holders: 220
Total Value: $1,221,372,117
Total Shares: 34,496,668
Showing 1–100 of 225 holdings by value · page 1 of 3

Institutional Ownership Trend

27 quarters

Holder Concentration

Share of 13F common-share value, across 220 filers with any position, options included · Δ vs Jun 30, 2026
Top Holder
21.5%
Dec 2023 → Sep 2026 · range 20.6% – 29.4%
+0.0 pts
Top 5
44.7%
Dec 2023 → Sep 2026 · range 44.7% – 67.0%
−1.5 pts
Top 10
62.1%
Dec 2023 → Sep 2026 · range 62.1% – 78.1%
−1.1 pts
HHI
699
Dec 2023 → Sep 2026 · range 684 – 1,503
Broadly held−15

Who Holds ASTH

Last 8 quarters through Sep 30, 2026

Each kind of 13F filer's share of the common shares 13F filers report. Holder type comes from regulatory records, never the filer's name; style, turnover and horizon are measured from each filer's own 13F book. The quarter selector does not change this card.

Sep 30, 2026: 218 filers, like-for-like change +7.6%; actively managed books +8.2%; index-like books +6.8%.

Holder type Share Filers Change
Registered adviser 43.4% 106 +4.8%
Exempt adviser 0.2% 2 new
Adviser 1.5% 5 -44.8%
Bank 13.9% 13 +11.5%
Insurer 0.9% 2 +2.1%
Broker-dealer 0.7% 2 +1.0%
Benefit plan 0.4% 6 +16.2%
Non-US 2.4% 9 +48.7%
Holding company 31.1% 8 +10.2%
Unknown 5.4% 65 +18.6%
How the mix is measured

Shares are 13F common shares restated to today's split basis; options and principal amounts are left out. The change compares only filers with a 13F in both quarters and keeps each filer in its bucket of the later quarter on both sides; a filer that continues under a new CIK is compared through its successor. Holder type comes from each filer's current regulatory profile; client base and private funds come from the Form ADV roster current at each quarter end (rosters from December 2019, so an earlier quarter reads Unknown). Style, turnover, horizon and book size are measured from each filer's 13F book in the newest measured quarter, and Not measured means none was. Actively managed books are those measured systematic-like, concentrated or diversified active.

Excluded 3 holders with no observed 2026-06-30 13F and 4 holders with no observed 2026-09-30 13F.

Conviction and Crowding

218 13F filers, quarter ended Sep 30, 2026

Measured across every 13F filer's common-share book once the quarter's filing window closed. Crowding counts filers with high turnover or that advise private funds on Form ADV.

Conviction holders
1
0.459% of filers hold it in their top 10
Jun 30, 2026: 2
Holders above 5%
1
median weight 0.002%
Jun 30, 2026: 1
Crowding
13.4%
of shares outstanding, 39th percentile
Jun 30, 2026: 12.4%
Private-fund advisers
13.0%
of shares outstanding
Institutional ownership
61.9%
108.9% of the estimated free float above 100%: filers can report lent or client shares more than once
Top 10 holders
61.8%
of 13F shares, Herfindahl 0.069
Active holders
+8.2%
like-for-like share change of active filers
5% stakes on record
3
1 13D, 2 13G (2 institutional, 0 passive, 0 exempt)
How long holders have held it value-weighted 14.3 quarters
Under 1 year 19.7% 1 to 3 years 35.4% 3 years or more 44.9% Since coverage start 0.000%

Managers in the top fifth by current three-year FundScore alpha were net buyers of $18,019,613 (6 buying, 1 selling).

Estimated Holder Cost Basis

Quarter ended Sep 30, 2026, on that quarter's share basis

Estimated, never filed: each 13F buy is costed at its quarter's average traded price and each sale keeps the average cost, so this is what holders paid on average if they traded evenly through each quarter.

Estimated avg cost
$35.30
estimated per share
Jun 30, 2026: $34.35
Quarter-end price
$35.41
implied by 13F values
Estimated gain or loss
+0.3%
price against the estimated cost
Estimated at a loss
42.1%
of costed 13F value

Estimated cost covers 32.8% of the 13F shares; positions already held when a filer's 13F history starts, or bought in a quarter without a trusted average price, have no estimate.

Shared Holders

Companies ASTH's active holders also own, quarter ended Sep 30, 2026
# Company Shared holders
1 DGII Digi International Inc 3
2 ENVA Enova International, Inc. 3
3 WAY Waystar Holding Corp. 3
4 TGTX Tg Therapeutics, Inc. 3
5 LGND Ligand Pharmaceuticals Inc 3
6 AXSM Axsome Therapeutics, Inc. 3
7 ARW Arrow Electronics, Inc. 3
8 GMED Globus Medical Inc 3
9 NBIX Neurocrine Biosciences Inc 3
10 SN SharkNinja, Inc. 3

Shareholder Targets

13F filers that own its peers but not ASTH, quarter ended Sep 30, 2026

Found through its holder-overlap peers: DGII, ENVA, WAY, TGTX, LGND, AXSM, ARW, GMED, NBIX, SN, MLI, SNX, ILMN, UTHR, BIIB, CNC, FANG, REGN, LRCX, VRT. 4,030 filers in all.

# Filer In peers
1 ARROWSTREET CAPITAL, LIMITED PARTNERSHIP Registered adviser, Diversified active $5,913,616,303 12 held
2 Capital World Investors Adviser, Diversified active $5,879,980,788 8 held
3 Amundi Holding company, Index-like $5,532,570,244 20 held
4 PRIMECAP MANAGEMENT CO/CA/ Registered adviser, Diversified active $4,488,499,145 5 held
5 Dodge & Cox Registered adviser, Diversified active $4,401,121,117 2 held
6 VAN ECK ASSOCIATES CORP Registered adviser, Index-like $4,116,462,387 15 held
7 COATUE MANAGEMENT LLC Registered adviser, Diversified active $3,455,439,307 2 held
8 WCM INVESTMENT MANAGEMENT, LLC Registered adviser, Diversified active $2,890,388,858 6 held
9 Swedbank AB Unknown, Diversified active $2,647,008,056 10 held
10 NORDEA INVESTMENT MANAGEMENT AB Non-US, Diversified active $2,563,736,371 15 held

Fund Ownership of ASTH by Fund Type

Registered funds' Form N-PORT reports for the quarter ended Jun 30, 2026

Index funds and index ETFs hold 22.52% of shares outstanding.

Fund type Of shares outstanding Shares
Index funds 3.87% 2,158,383
Index ETFs 18.66% 10,410,469
Active ETFs 1.10% 615,061
Active funds 4.56% 2,545,981
Unclassified 0.17% 97,206
All registered funds 28.36% 15,827,100
How fund types are measured

Each fund series counts once, with its latest Form N-PORT report dated inside the quarter; only long share positions count, restated to today's split basis. The fund type is the series' latest Form N-CEN answer on or before the quarter end (the index-fund box and the exchange-traded flag), never its name. Unclassified funds have no usable N-CEN; unit investment trusts are among them, so index ownership is a floor. Funds sit inside their advisers' 13F reports, so these shares overlap the 13F figures and are never added to them.

Quarterly Activity

vs Jun 30, 2026
New
32
Increased
81
Decreased
70
Sold Out
25
Unchanged
34

New and Sold Out count only filers that reported a 13F for both quarters: a first-time filer's book is not a buy, and a fund that has not filed, or withheld its positions under confidential treatment, has not sold.

Holder count: +6
Institutional value: -18.0%
Shares held: +7.3%

Top Buyers

vs Jun 30, 2026
Institution Added Now Holds Open

Top Sellers

vs Jun 30, 2026
Institution Sold Now Holds Open

Top New Positions

vs Jun 30, 2026
Institution Acquired Value (USD) Open

Top Sold-Out Positions

vs Jun 30, 2026
Institution Previously Held Last Value (USD) Open
Showing 100 of 225
Export CSV
Holder Value (USD) % of 13F Shares Own % Change Type Filed Open

Showing the top 100 of 225 holders. Create a free account to see every holder, past quarters, search, filters and CSV export.

Key facts CIK 1083446 CUSIP 03763A207 13F (30d) 218 filings 198 filers Visit website Investor relations